GB201505532D0 - Formulations - Google Patents
FormulationsInfo
- Publication number
- GB201505532D0 GB201505532D0 GBGB1505532.0A GB201505532A GB201505532D0 GB 201505532 D0 GB201505532 D0 GB 201505532D0 GB 201505532 A GB201505532 A GB 201505532A GB 201505532 D0 GB201505532 D0 GB 201505532D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1505532.0A GB201505532D0 (en) | 2015-03-31 | 2015-03-31 | Formulations |
PCT/EP2016/057027 WO2016156470A1 (en) | 2015-03-31 | 2016-03-31 | Vesicular formulations for use in the treatment of muscle soreness |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1505532.0A GB201505532D0 (en) | 2015-03-31 | 2015-03-31 | Formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201505532D0 true GB201505532D0 (en) | 2015-05-13 |
Family
ID=53178429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1505532.0A Ceased GB201505532D0 (en) | 2015-03-31 | 2015-03-31 | Formulations |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201505532D0 (en) |
WO (1) | WO2016156470A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20140021950A (en) * | 2009-06-03 | 2014-02-21 | 존 찰스 마요 | Formulations for the treatment of deep tissue pain |
GB201206486D0 (en) * | 2012-04-12 | 2012-05-30 | Sequessome Technology Holdings Ltd | Vesicular formulations and uses thereof |
-
2015
- 2015-03-31 GB GBGB1505532.0A patent/GB201505532D0/en not_active Ceased
-
2016
- 2016-03-31 WO PCT/EP2016/057027 patent/WO2016156470A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2016156470A1 (en) | 2016-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273541A (en) | Formulations | |
IL268697A (en) | Formulations | |
PL3337502T3 (en) | Stable anti-ifnar1 formulation | |
IL269630A (en) | Niraparib formulations | |
IL269621A (en) | Niraparib formulations | |
IL273282A (en) | Niraparib formulations | |
IL265609A (en) | Novel formulations | |
GB201513010D0 (en) | Novel formulation | |
GB201607918D0 (en) | Novel formulations | |
GB201514758D0 (en) | Formulation | |
GB201419261D0 (en) | Formulations | |
GB201419091D0 (en) | Formulations | |
HK1254980A1 (en) | Blended formulations | |
HUE054584T2 (en) | Maropitant formulation | |
GB201521771D0 (en) | Formulation | |
GB201511255D0 (en) | Formulation | |
GB201509891D0 (en) | Formulation | |
GB201621277D0 (en) | Formulations | |
GB201714461D0 (en) | Formulations | |
GB201618110D0 (en) | Formulations | |
GB201616366D0 (en) | Formulations | |
GB201615754D0 (en) | Formulations | |
GB201617866D0 (en) | Novel formulations | |
GB201616509D0 (en) | Novel formulations | |
GB201507784D0 (en) | Formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S30Z | Assignments for licence or security reasons |
Free format text: APPLICANT. SEQUESSOME TECHNOLOGY HOLDIGS LIMITED SECURITY INTEREST. FONDS RUSNANO CAPITAL S.A. |
|
AT | Applications terminated before publication under section 16(1) |